Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 2Bayer Inc.
02 1Pediapharm Inc
01 22414271
02 12790652
01 1CIPROFLOXACIN HYDROCHLORIDE | FLUOCINOLONE ACETONIDE
02 2Ciprofloxacin Hydrochloride | Ciprofloxacin
01 2Extended Release Tablet
02 1SOLUTION
01 22021-06-13
02 12031-02-28
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2021-06-13
Date Granted : 2005-09-27
Ciprofloxacin Hydrochloride, Ciprofloxacin
Brand Name : CIPRO XL
Patent Number : 2414271
Filing Date : 2001-06-13
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-06-13
Date Granted : 2005-09-27
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2021-06-13
Date Granted : 2005-09-27
Ciprofloxacin Hydrochloride, Ciprofloxacin
Brand Name : CIPRO XL
Patent Number : 2414271
Filing Date : 2001-06-13
Strength per Unit : 1000 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-06-13
Date Granted : 2005-09-27
Patent Expiration Date : 2031-02-28
Date Granted : 2016-11-08
CIPROFLOXACIN HYDROCHLORIDE, FLUOCINOLONE ACETONIDE
Brand Name : OTIXAL
Patent Number : 2790652
Filing Date : 2011-02-28
Strength per Unit : 0.3% / 0.025% w / v
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : OTIC
Patent Expiration Date : 2031-02-28
Date Granted : 2016-11-08
